Status:
COMPLETED
Intravenous Remifentanil Plus Morphine or Morphine Alone for Postthoracotomy Pain
Lead Sponsor:
Cukurova University
Conditions:
Pain
Eligibility:
All Genders
18-59 years
Phase:
PHASE4
Brief Summary
Background; Post-thoracotomy pain remains a major problem. This double-blind, randomized study tested the effects of coadministration of patient controlled remifentanil+morphine combination on posttho...
Detailed Description
Methods; Sixty patients were allocated randomly to receive an intravenous patient-controlled analgesia with morphine alone (M), or morphine plus remifentanil (MR), in a double-blind manner. Postoperat...
Eligibility Criteria
Inclusion
- 60 ASA physical status I-III patients, between the ages of 18 and 59 years, scheduled for elective thoracotomy surgery with general anaesthesia were included in this study
Exclusion
- severe hepatorenal disease history, sensitivity or contraindication to morphine and remifentanil, chronic pain (defined as regular use of opioid analgesics for \> 3 months), drug or alcohol abuse and contraindication to administration of PCA
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01830296
Start Date
May 1 2011
End Date
December 1 2012
Last Update
April 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hakkı Unlugenc
Adana, Turkey (Türkiye), 01330